Skip to content
Accent Microcell logo

Accent Microcell

ACCENTMIC NSE
₹633.45 up 12.20 (1.96%)
Market Cap
₹1,520 Cr
P/E
115.17

Accent Microcell (ACCENTMIC) share price was ₹621.25 at the 28 Oct 2026 close; market capitalisation ₹1,490 Cr; P/E (TTM) 112.95; sector Chemicals. The share price rose 132.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Sep 2026 quarter, revenue rose 25.9% year on year to ₹175 Cr and net profit was ₹31 Cr, against ₹18 Cr a year earlier (compared with Sep 2025). Promoters held 51.40% of Accent Microcell in Sep 2026, down 1.62 percentage points from Jun 2026. Its Tapetide Score is 45/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹621.25 +355.25 +133.55% 1Y

Key Fundamentals

SMEChemicals & PetrochemicalsChemicals
Market Cap
₹1,520 Cr
P/E (TTM)
115.17
EBITDA
₹63.50 Cr
Return on Equity
15.92%
Debt to Equity
0
Book Value
₹114.84
EPS (TTM)
₹5.50
52W High
₹731.70
52W Low
₹253.00

Price-based figures as of 29 Oct 2026, 10:36 IST · TTM

Peer Comparison

Healthcare › Chemicals › Specialty Chemicals › Pharmaceuticals

Sun Pharma
₹1,764.0034.994,23,243 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,667.5087.742,56,642 Cr15.310.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,590.6072.071,74,612 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,194.10108.401,18,550 Cr22.370.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.9026.341,18,094 Cr4.360.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.7032.721,10,329 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Accent Microcell (this company)
₹633.45115.171,520 Cr5.520.16%15.92%21.14%60 Cr7 Cr
Median 8 companies₹1,564.8553.531,18,322 Cr5.290.47%14.56%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

45 Average
Overall score

Data confidence 100/100

Category scores

Quality Average 48
Returns, margins, earnings quality 22% weight
Valuation Poor 18
Cheap vs sector & own history 24% weight
Growth Strong 97
Sales & profit trajectory 9% weight
Financial Health Strong 87
Solvency, leverage, coverage 9% weight
Momentum Strong 77
Trend strength, vol-adjusted 12% weight
Ownership Poor 7
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 54.3% CAGR over last 5 years

Weaknesses

1
  • Promoter holding has decreased over last quarter: -1.62%

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
8
Neutral
7
Bullish
4

Moving Averages

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
31.29% higher than 3Y

change over 1 year

Net Income Growth
32.63% lower than 3Y

change over 1 year

Cash Flow Change
-24.44%

change over 1 year

EBITDA Margin Change
0.06%

change over 1 year Operating margin 24% · Sep 2026

Quarterly Results

Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Sales
107
139
126
139
139
210
175
Expenses
87
119
107
115
115
177
134
Operating Profit
20
20
19
23
24
33
41
OPM %
18%
14%
15%
17%
17%
16%
24%
Other Income
1
2
3
3
3
4
3
Interest
1
0
0
0
0
0
0
Depreciation
2
2
2
2
2
3
2
PBT
17
19
20
24
24
34
41
Tax %
18%
17%
16%
32%
25%
25%
25%
Net Profit
14
16
16
17
18
26
31
EPS (₹)
8.01
6.7
6.86
6.92
7.53
10.75
12.97
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
114
131
133
166
197
246
265
349
384
Expenses
108
122
122
153
178
206
223
292
310
Operating Profit
6
9
11
13
19
39
42
57
74
OPM %
4.9%
7%
8%
8%
10%
16%
16%
16%
19%
Other Income
6
4
2
2
2
3
6
7
7
Interest
3
3
3
3
3
1
0
1
0
Depreciation
3
3
4
4
4
4
4
5
5
PBT
5
6
6
8
15
37
44
58
76
Tax %
24%
31%
20%
22%
17%
17%
24%
25%
—
Net Profit
4
4
5
6
12
30
33
44
57
EPS (₹)
2.46
2.84
3.27
4.01
8.26
12.57
13.78
18.28
23.72
Div. Payout %
0%
0%
9%
18%
8%
7%
6%
5%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
4
4
4
13
13
21
21
24
24
Reserves
17
21
22
19
37
143
174
252
280
Borrowings
32
30
31
24
23
13
2
1
1
Other Liabilities
20
22
23
38
37
28
32
45
41
Total Liabilities
73
77
81
95
111
205
228
322
346
Fixed Assets
30
29
30
30
31
29
48
53
56
CWIP
0
0
0
0
0
2
13
102
135
Investments
0
0
0
0
0
0
0
0
0
Other Assets
43
48
50
64
79
174
168
167
155
Total Assets
73
77
81
95
111
205
228
322
346
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
5
5
15
8
11
25
19
Investing
-4
-2
-6
-4
-4
-82
-9
-49
Financing
-1
-2
-2
-10
-4
72
-14
36
Net Cash Flow
1
1
-3
1
-1
1
2
6
Free Cash Flow
2
3
0
11
3
-2
-12
-68
CFO/EBITDA
120
72
57
127
53
44
85
56
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
70
60
35
38
56
80
89
95
Inventory Days
67
78
128
128
128
83
76
55
Days Payable
89
80
74
97
106
48
42
33
Cash Conversion Cycle
48
58
88
68
79
114
124
117
Working Capital Days
19
30
37
16
41
79
101
95
ROCE %
—
18%
17%
19%
27%
31%
24%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Accent Microcell insights

69 extracted metrics + investor summaries across FY19–FY27.

Shareholding Pattern

FIIs0.72%Promot.51.40%DIIs2.43%Others9.87%Public35.58%As ofSep 2026

Documents

Frequently Asked Questions about Accent Microcell

What does Accent Microcell Ltd do?
Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]
Where is Accent Microcell Ltd (ACCENTMIC) listed?
Accent Microcell Ltd trades as ACCENTMIC on the NSE.
Which sector does Accent Microcell Ltd belong to?
Accent Microcell Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Accent Microcell Ltd?
Accent Microcell Ltd has a market capitalisation of ₹1,520 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Accent Microcell Ltd?
Accent Microcell Ltd trades at a PE ratio of 115.17 as of 29 Oct 2026, on earnings per share of ₹5.5, against a book value of ₹114.84 per share.
What is the 52-week high and low of Accent Microcell Ltd?
Over the last 52 weeks Accent Microcell Ltd has traded between ₹253 and ₹731.7 as of 29 Oct 2026.
Does Accent Microcell Ltd pay dividends?
Accent Microcell Ltd has a dividend yield of 0.16%.
What is the Return on Equity (ROE) of Accent Microcell Ltd?
Accent Microcell Ltd reported a return on equity of 15.92%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]

Website accentmicrocell.com
Listed 2023-12-15
Face Value ₹ 10
Shares Outstanding 2,39,89,020

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ACCENTMIC.md for Accent Microcell Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month